Send Inquiry

Request To Call Back

1mg Anastrozole Tablets Ip

Get a Price/Quote

MOQ : 10 Boxes

1mg Anastrozole Tablets Ip Specification

Appearance
White to off-white, round, biconvex film-coated tablets

Pacakaging (Quantity Per Box)
1 x 10 tablets

CAS No
120511-73-1

Grade
Pharmaceutical Grade

Expiration Date
24 to 36 months from date of manufacture

Usage
Used in the treatment of breast cancer

Origin of Medicine
India

Dosage Form
Film-coated tablet

Molecular Formula
C17H19N5

Storage
Store below 30C, protected from light and moisture

Medicine Type
Tablet

Dosage
1 mg

Indication
Indicated for hormone receptor-positive early breast cancer and advanced or metastatic breast cancer in postmenopausal women

Salt Composition
Anastrozole 1 mg

Assay
99% - 101%

Drug Strength
1 mg

Route of Administration
Oral

Shelf Life
24 to 36 months

Colour
White to off-white

Regulatory Compliance
WHO-GMP/ISO certified manufacturing

Marketed In
Africa, Asia, Latin America, CIS, Middle East

Therapeutic Class
Antineoplastic agent, Aromatase inhibitor

Prescription Required
Yes

Side Effects
Hot flashes, weakness, joint pain, nausea, headache

Directions for Use
As directed by physician

Warning & Precautions
Not to be used in premenopausal women or during pregnancy

Brand Name
Anastrozole Tablets IP

Pack Type
Blister pack strip

1mg Anastrozole Tablets Ip Trade Information

Minimum Order Quantity
10 Boxes

Payment Terms
Cash Against Delivery (CAD), Cash on Delivery (COD), Cash in Advance (CID)

Supply Ability
50 Boxes Per Month

Delivery Time
5-7 Days

Main Domestic Market
All India

About 1mg Anastrozole Tablets Ip

Unlock exceptional savings on elite cancer care with our Anastrozole Tablets IP 1mg, designed for optimum therapeutic effect in treating hormone receptor-positive breast cancer in postmenopausal women. This pharmaceutical-grade, WHO-GMP/ISO certified antineoplastic agent promises not just a bargain but an impeccable standard of safety and efficacy. Each film-coated, white to off-white tablet embodies maximum potency (Assay: 99%-101%) and long-lasting shelf life (24-36 months). Enjoy discounted global supply from a trusted exporter and supplier in India, packed securely in blister strips for renowned quality and peace of mind.

Precise Application and Dosage of Anastrozole Tablets IP

Anastrozole Tablets IP 1mg is specifically indicated for postmenopausal women with hormone receptor-positive early or advanced breast cancer. Administered orally, the dosage is typically one tablet daily, or as directed by the physician for optimum results. The treatment is intended for use as an antineoplastic agent within the therapeutic class of aromatase inhibitors, making it suitable for both specific and general oncological protocols. For maximum benefit, this medication must be used under medical supervision, strictly following prescribed directions.

Sample Policy, Quick Dispatch, and Accreditation

Samples of Anastrozole Tablets IP 1mg can be provided upon receipt of a formal purchase order, ensuring confidence in our product's quality and performance before bulk supply. We guarantee prompt dispatch and timely delivery to meet our clients' schedules across Africa, Asia, Latin America, and more. Manufactured under rigorous WHO-GMP and ISO certifications, our processes align with global pharmaceutical standards, prioritizing both safety and reliability in every supply consignment.

FAQ's of 1mg Anastrozole Tablets Ip:

Q: How should Anastrozole Tablets IP 1mg be administered?

A: Anastrozole Tablets IP 1mg must be taken orally, usually once daily, strictly as directed by a qualified physician. Always follow prescribed instructions for optimum results.

Q: What are the primary benefits of Anastrozole Tablets IP?

A: Anastrozole Tablets IP is highly effective for managing hormone receptor-positive breast cancer in postmenopausal women, acting as an aromatase inhibitor to limit estrogen production essential for cancer growth.

Q: When can I expect the delivery after placing a purchase order?

A: Delivery timelines are efficient; once your purchase order is confirmed, samples or product orders are promptly dispatched to ensure timely supply across designated regions.

Q: What certifications do Anastrozole Tablets IP 1mg comply with?

A: Our product is manufactured in facilities accredited with WHO-GMP and ISO certifications, ensuring impeccable manufacturing standards, safety, and regulatory compliance.

Q: Where is Anastrozole Tablets IP available for market supply?

A: We supply and export Anastrozole Tablets IP to Africa, Asia, Latin America, CIS, and the Middle East, meeting diverse market needs with reliable distribution.

Q: What side effects are associated with this medication?

A: Potential side effects may include hot flashes, weakness, joint pain, nausea, and headache. Patients should consult their physician immediately if adverse reactions occur.

Tell us about your requirement